193 related articles for article (PubMed ID: 16430777)
1. Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer.
Jiang WG; Watkins G; Douglas-Jones A; Holmgren L; Mansel RE
BMC Cancer; 2006 Jan; 6():16. PubMed ID: 16430777
[TBL] [Abstract][Full Text] [Related]
2. Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin.
Martin TA; Watkins G; Lane J; Jiang WG
Histopathology; 2005 Apr; 46(4):422-30. PubMed ID: 15810954
[TBL] [Abstract][Full Text] [Related]
3. Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.
Jiang WG; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE; Fodstad O
Int J Cancer; 2005 Dec; 117(5):730-7. PubMed ID: 15957166
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.
Horak ER; Leek R; Klenk N; LeJeune S; Smith K; Stuart N; Greenall M; Stepniewska K; Harris AL
Lancet; 1992 Nov; 340(8828):1120-4. PubMed ID: 1279332
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of angiomotin in sinonasal inverted papilloma.
Byun JY; Lee SH; Shin JM; Baek BJ; Lee JY
Int Forum Allergy Rhinol; 2014 Jun; 4(6):512-6. PubMed ID: 24532565
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance.
Davies G; Rmali KA; Watkins G; Mansel RE; Mason MD; Jiang WG
Int J Oncol; 2006 Nov; 29(5):1311-7. PubMed ID: 17016666
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.
Jiang WG; Douglas-Jones AG; Mansel RE
Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620
[TBL] [Abstract][Full Text] [Related]
8. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo.
Levchenko T; Veitonmäki N; Lundkvist A; Gerhardt H; Ming Y; Berggren K; Kvanta A; Carlsson R; Holmgren L
FASEB J; 2008 Mar; 22(3):880-9. PubMed ID: 17984175
[TBL] [Abstract][Full Text] [Related]
10. The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells.
Sahni A; Arévalo MT; Sahni SK; Simpson-Haidaris PJ
Int J Cancer; 2009 Aug; 125(3):577-84. PubMed ID: 19358279
[TBL] [Abstract][Full Text] [Related]
11. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].
Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P
Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873
[TBL] [Abstract][Full Text] [Related]
12. The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer.
Kang H; Watkins G; Douglas-Jones A; Mansel RE; Jiang WG
Breast; 2005 Oct; 14(5):360-7. PubMed ID: 16216737
[TBL] [Abstract][Full Text] [Related]
13. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
Yang J; Liu P; Tian M; Li Y; Chen W; Li X
Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
[TBL] [Abstract][Full Text] [Related]
14. The Angiomotins--from discovery to function.
Moleirinho S; Guerrant W; Kissil JL
FEBS Lett; 2014 Aug; 588(16):2693-703. PubMed ID: 24548561
[TBL] [Abstract][Full Text] [Related]
15. Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin.
Stalin J; Harhouri K; Hubert L; Subrini C; Lafitte D; Lissitzky JC; Elganfoud N; Robert S; Foucault-Bertaud A; Kaspi E; Sabatier F; Aurrand-Lions M; Bardin N; Holmgren L; Dignat-George F; Blot-Chabaud M
J Biol Chem; 2013 Mar; 288(13):8991-9000. PubMed ID: 23389031
[TBL] [Abstract][Full Text] [Related]
16. Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.
Hong SA; Son MW; Cho J; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee MS
APMIS; 2017 Nov; 125(11):996-1006. PubMed ID: 28885730
[TBL] [Abstract][Full Text] [Related]
17. Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance.
Cheng S; Douglas-Jones A; Yang X; Mansel RE; Jiang WG
Cancer Genomics Proteomics; 2010; 7(2):67-73. PubMed ID: 20335520
[TBL] [Abstract][Full Text] [Related]
18. p73 is required for vessel integrity controlling endothelial junctional dynamics through Angiomotin.
Maeso-Alonso L; Alonso-Olivares H; Martínez-García N; López-Ferreras L; Villoch-Fernández J; Puente-Santamaría L; Colas-Algora N; Fernández-Corona A; Lorenzo-Marcos ME; Jiménez B; Holmgren L; Wilhelm M; Millan J; Del Peso L; Claesson-Welsh L; Marques MM; Marin MC
Cell Mol Life Sci; 2022 Oct; 79(10):535. PubMed ID: 36180740
[TBL] [Abstract][Full Text] [Related]
19. High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer.
Salhab M; Patani N; Jiang W; Mokbel K
Breast Cancer; 2012 Apr; 19(2):153-60. PubMed ID: 20972741
[TBL] [Abstract][Full Text] [Related]
20. Angiomotin promotes breast cancer cell proliferation and invasion.
Lv M; Lv M; Chen L; Qin T; Zhang X; Liu P; Yang J
Oncol Rep; 2015 Apr; 33(4):1938-46. PubMed ID: 25647626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
